May 8, 2019 / 5:18 AM / 18 days ago

BRIEF-Roche Presents New Ocrevus Data

May 8 (Reuters) - Roche Holding AG:

* ROCHE TO PRESENT NEW OCREVUS (OCRELIZUMAB) DATA ANALYSES SHOWING SIGNIFICANT REDUCTION OF DISABILITY PROGRESSION IN RELAPSING AND PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS AT THE AAN ANNUAL MEETING

* NEW ANALYSES SHOW THE EFFECT OF OCREVUS ON REDUCING THE RISK OF DISABILITY PROGRESSION IS ASSOCIATED WITH EXPOSURE AND LOWER B-CELL LEVELS

* LONG-TERM DATA IN RMS AND PPMS SHOW THAT EARLIER TREATMENT WITH OCREVUS SIGNIFICANTLY REDUCED THE RISK OF PERMANENT DISABILITY PROGRESSION Source text for Eikon: Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below